Eiger BioPharmaceuticals, Inc. (EIGR) Cash Flow Annual - Discounting Cash Flows
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
06-30
Report Filing: 2023-12-31 2023-12-31 2023-03-17 2022-03-10 2021-03-09 2020-03-13 2019-03-14 2018-03-09 2017-03-23 2016-03-30 2015-03-31 2014-03-31 2012-12-31 2011-06-30
Net Income/Starting Line -74.96 -74.96 -96.78 -33.92 -65.05 -70.25 -52.39 -42.45 -47.09 -44.41 -33.85 -20.09 -15.87 -6.99
Cash From Operating Activities -74.55 -74.55 -83.01 -71.34 -63.19 -63.61 -42.67 -38.37 -37.97 -41.09 -29.26 -16.2 -14.64 -5.61
Depreciation and Amortization 0.75 0.75 0.842 0.799 0.645 0.486 0.054 0.041 0.023 0.504 0.153 0.067 0.064 0.073
Deferred Income Tax -1.1 0 0 -45.5 0.124 -0.467 -0.426 -0.253 0.124 0.388 0.577 0.417 0.124 0.092
Stock Based Compensation 5.01 5.01 8.32 7.9 5.97 5.68 5.01 4.24 3.19 3.03 3.32 1.39 0.298 0
Other Non-Cash Items 1.49 0.39 4.13 0.713 1.02 0.949 1.02 0.366 4.06 1.53 0.462 0.076 0.136 1.12
Changes in Working Capital -5.73 -5.73 0.481 -1.34 -5.9 -0.009 4.07 -0.321 1.72 -2.13 0.083 1.95 0.612 -0.126
Accounts Receivable 0.084 0.084 0.828 -2.58 0 0 0 0 0 0 0 0 0 0
Inventory 1.63 1.63 -1.37 -2.42 0 0 0 0 0 0 0 0 0 0
Accounts Payable -6.83 -6.83 1.15 3.23 -1.9 0.584 2.65 0.544 0.699 -4.27 2.94 1.84 0 0
Deferred Revenue -0.608 -0.608 -0.132 0.425 -4 -0.593 1.42 -0.865 1.02 2.14 -2.85 0.104 0 0
Other Working Capital 0 0 0 0 0 0 0 0 0 0 0 0 0.612 -0.126
Cash From Investing Activities 74.23 74.23 9.63 61.53 -44.79 -16.47 -29.09 22.66 -4.19 70.37 -61.19 10.85 -21.83 0.035
Investments in Property Plant and Equipment -0.234 -0.234 -0.34 -48.73 -0.258 -0.475 -0.142 -0.044 -0.058 -0.235 -0.739 -0.087 -0.048 -0.002
Payments for Acquisitions -13.6 0 -9.97 46.49 44.53 16 0 0 28.02 0 0 0 0 0
Purchases of Securities -19.39 -19.39 -75.1 -84.65 -128.3 -96.27 -57.19 -24.52 -34.15 0 -90.66 -17.86 -26.75 0
Sales and Maturities of Investments 93.85 93.85 85.07 99.63 83.77 80.27 28.25 47.02 2 70.33 30.21 28.8 4.97 0
Other Investing Activities 62.46 0 9.97 48.79 -44.53 -16 -28.94 0.2 28.02 0.277 0 0 0 0.037
Cash From Financing Activities 0.041 0.041 76.95 3.34 97.46 58.2 101 19.99 65.14 -10.94 96.98 -0.596 49.84 4.47
Debt Repayment 0 0 6.56 0 0 4.96 9.94 0 14.76 5.98 10 1.1 -0.111 0
Common Stock Issued 0.034 0 71.4 3.04 96.78 53.19 90.64 19.8 50.34 0.826 95.03 0 0 0.09
Common Stock Repurchased 7,337 0 0 0 0 0 0 0 0 0 -7.66 -1.69 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0.041 0.041 -1.01 0.127 0.684 0.042 0.406 0.194 0.046 6.38 -0.388 0 49.95 4.47
Effect of Forex Changes on Cash -0.079 -0.079 0 0 0 0 0 0 0 0 0 0 0 0
Net Change in Cash 10.26 -0.358 3.58 -6.64 -10.51 -21.89 29.23 4.28 22.98 18.34 6.53 -5.94 13.37 -1.1
Cash at Beginning of Period 15.18 25.8 22.22 28.86 39.37 61.26 32.03 27.76 4.78 14.44 7.9 13.84 0.468 1.7
Cash at End of Period 25.44 25.44 25.8 22.22 28.86 39.37 61.26 32.03 27.76 32.78 14.44 7.9 13.84 0.6
Free Cash Flow -74.78 -74.78 -83.35 -120.1 -63.44 -64.09 -42.81 -38.42 -38.03 -41.33 -30 -16.28 -14.69 -5.61
Operating Cash Flow -74.55 -74.55 -83.01 -71.34 -63.19 -63.61 -42.67 -38.37 -37.97 -41.09 -29.26 -16.2 -14.64 -5.61
Capital Expenditure -0.234 -0.234 -0.34 -48.73 -0.258 -0.475 -0.142 -0.044 -0.058 -0.235 -0.739 -0.087 -0.048 -0.002
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us